These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10495473)

  • 1. ACE, PAI-1, decorin and Werner helicase genes are not associated with the development of renal disease in European patients with type 1 diabetes.
    De Cosmo S; Margaglione M; Tassi V; Garrubba M; Thomas S; Olivetti C; Piras GP; Trevisan R; Vedovato M; Cavallo Perin P; Bacci S; Colaizzo D; Cisternino C; Zucaro L; Di Minno G; Trischitta V; Viberti GC
    Diabetes Metab Res Rev; 1999; 15(4):247-53. PubMed ID: 10495473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
    Kimura H; Gejyo F; Suzuki Y; Suzuki S; Miyazaki R; Arakawa M
    Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DD genotype of the ACE gene polymorphism is associated with diabetic nephropathy in the type-1 diabetics.
    Azar ST; Zalloua PA; Medlej R; Halabi G
    Endocr Res; 2001; 27(1-2):99-108. PubMed ID: 11428725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients.
    Wong TY; Poon P; Szeto CC; Chan JC; Li PK
    Kidney Int; 2000 Feb; 57(2):632-8. PubMed ID: 10652041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of plasminogen activator inhibitor-1 gene polymorphism and type 2 diabetic nephropathy.
    Xu F; Liu H; Sun Y
    Ren Fail; 2016; 38(1):157-62. PubMed ID: 26616527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics.
    Ohno T; Kawazu S; Tomono S
    Metabolism; 1996 Feb; 45(2):218-22. PubMed ID: 8596493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Decorin gene 179 allelic variant is associated with a slower progression of renal disease in patients with type 1 diabetes.
    De Cosmo S; Tassi V; Thomas S; Piras GP; Trevisan R; Cavallo Perin P; Bacci S; Zucaro L; Cisternino C; Trischitta V; Viberti GC
    Nephron; 2002 Sep; 92(1):72-6. PubMed ID: 12187087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group.
    Schmidt S; Schöne N; Ritz E
    Kidney Int; 1995 Apr; 47(4):1176-81. PubMed ID: 7783416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism, and diabetic retinopathy in subjects with IDDM and NIDDM.
    Nagi DK; Mansfield MW; Stickland MH; Grant PJ
    Diabet Med; 1995 Nov; 12(11):997-1001. PubMed ID: 8582133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between the insertion/deletion polymorphism of the angiotensin-converting-enzyme gene and diabetic nephropathy in IDDM patients.
    Pfohl M; Frost D; Koch M; Clemens P; Patzies A; Schmülling RM; Beischer W; Häring HU
    Horm Metab Res; 1998 May; 30(5):276-80. PubMed ID: 9660089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
    Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy.
    Tarnow L; Cambien F; Rossing P; Nielsen FS; Hansen BV; Lecerf L; Poirier O; Danilov S; Boelskifte S; Borch-Johnsen K
    Diabetologia; 1995 Jul; 38(7):798-803. PubMed ID: 7556981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients.
    Tarnow L; Cambien F; Rossing P; Nielsen FS; Hansen BV; Lecerf L; Poirier O; Danilov S; Parving HH
    Diabetes; 1995 May; 44(5):489-94. PubMed ID: 7729604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy.
    Tarnow L; Stehouwer CD; Emeis JJ; Poirier O; Cambien F; Hansen BV; Parving HH
    Nephrol Dial Transplant; 2000 May; 15(5):625-30. PubMed ID: 10809802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM.
    Chowdhury TA; Dronsfield MJ; Kumar S; Gough SL; Gibson SP; Khatoon A; MacDonald F; Rowe BR; Dunger DB; Dean JD; Davies SJ; Webber J; Smith PR; Mackin P; Marshall SM; Adu D; Morris PJ; Todd JA; Barnett AH; Boulton AJ; Bain SC
    Diabetologia; 1996 Sep; 39(9):1108-14. PubMed ID: 8877296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between plasminogen activator inhibitor-1 gene 4G/5G polymorphism and type 2 diabetic nephropathy in Chinese Han patients in Guangdong Province].
    Liu SQ; Xue YM; Yang GC; He FY; Zhao XS
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug; 24(8):904-7. PubMed ID: 15321757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control.
    Barnas U; Schmidt A; Illievich A; Kiener HP; Rabensteiner D; Kaider A; Prager R; Abrahamian H; Irsigler K; Mayer G
    Diabetologia; 1997 Mar; 40(3):327-31. PubMed ID: 9084972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between angiotensin I converting enzyme gene polymorphism and renal complications in Korean IDDM patients.
    Oh TG; Shin CS; Park KS; Kim SY; Cho BY; Lee HK; Koh CS
    Korean J Intern Med; 1996 Jun; 11(2):133-7. PubMed ID: 8854649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes.
    Margaglione M; Grandone E; Vecchione G; Cappucci G; Giuliani N; Colaizzo D; Celentano E; Panico S; Di Minno G
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2082-7. PubMed ID: 9351375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MTHFR C677T, A1298C and ACE I/D polymorphisms as risk factors for diabetic nephropathy among type 2 diabetic patients.
    El-Baz R; Settin A; Ismaeel A; Khaleel AA; Abbas T; Tolba W; Abd Allah W; Sobh MA
    J Renin Angiotensin Aldosterone Syst; 2012 Dec; 13(4):472-7. PubMed ID: 22554825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.